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Background
Targeted viral load (VL) strategy is followed in the ART
programme of India. Patients failing antiretroviral ther-
apy, undergo VL testing and switched to 2ndline ART if
VL is >5000 copies/ml.
Methods
Data of patients referred to School of Tropical Medicine,
Kolkata for suspected treatment failure (TF) was analyzed
for the period of December2008 to November2013 to
ascertain the positive predictive value (PPV) of immuno-
logic and/or clinical parameter for confirming virologic
failure (VF) and to observe the short term outcome of
secondline treatment. Paired t- test was used for data
analysis.
Results
VF was noted in 287(51.3%) of 560 patients (median age
37 years; male–436(77.85%); median CD4 109 cells/mm3
at suspected TF. Number of patients failing by immunolo-
gic, clinical and clinicoimmunologic criteria was 414(74%),
11(2%) & 135(24%) respectively with corresponding PPV
of 48%, 46% & 63% respectively. PPV of CD4 falling below
baseline, >50% drop from on-treatment peak value and
failure to reach 100 cells/mm3 after 12 months of ART
was 37%, 55% and 25% respectively. Among 216 patients
with minimum 6 months follow-up, the median CD4 &
VL changed significantly following 6 months of secondline
ART (103.5 to 232 cells/mm3; p<0.0001 and 4.04 to 2.6
log10 copies; p<0.0001 respectively). Undetectable VL was
achieved in 164(76%). Out of 284 patients starting second-
line ART, 25 (8.8%) died within 6 months.
Conclusion
Immunoclinical criteria have low PPV in diagnosing VF.
Despite late switch, majority (76%) could achieve unde-
tectable VL at 6 months but the high early mortality
(8.8%) is a concern.
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